-
Medical device maker AngioDynamics fights rival’s ‘extraordinary’ trial bill
Defendant C.R. Bard Inc prevailed at antitrust trial and seeks travel and other expenses AngioDynamics has appealed verdict to 2nd U.S. Circuit (Reuters) – Health care technological know-how corporation AngioDynamics Inc is bucking what it calls an “remarkable” exertion by a rival firm to recuperate hundreds of 1000’s of pounds in authorized expenses subsequent its earn at trial last thirty day period in New York federal district courtroom. Represented by lawyers at Cadwalader, Wickersham & Taft, AngioDynamics in a Nov. 25 courtroom filing urged Chief U.S. District Choose Brenda Sannes in Albany to reject most of the tab presented by C.R. Bard Inc for extra than $420,000 in prices tied…

/cloudfront-us-east-1.images.arcpublishing.com/gray/RDVQFPDBOZDOZHWUKCNS3ANKZU.jpg?w=500&resize=500,330&ssl=1)
